Based on KANEKA’s core technologies of macromolecules and biotech, we developed downstream bio processing materials, KanCapA™, KanCapA3G™ and innovative cell harvesting products. Our products offer good balance of price and performance with sufficient capability of antibody purification from development to commercial production stage.